Nimodipine Impurity 4, identified by its CAS number 116799-92-9, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent nimodipine, which is primarily used for the treatment of subarachnoid hemorrhage. As an impurity, it may arise during the synthesis or degradation of nimodipine and can affect the purity and efficacy of the final product. The compound typically exhibits characteristics common to organic molecules, including specific solubility profiles, stability under certain conditions, and potential reactivity with other chemical species. Its structural features may include functional groups that influence its chemical behavior, such as the presence of ester or amine groups. The identification and quantification of impurities like Nimodipine Impurity 4 are crucial in pharmaceutical development to ensure safety, efficacy, and compliance with regulatory standards. Analytical techniques such as high-performance liquid chromatography (HPLC) or mass spectrometry are often employed to detect and characterize such impurities in drug formulations.

Nimodipine Impurity 4

116799-92-9: Nimodipine Impurity 4, identified by its CAS number 116799-92-9, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent nimodipine, which is primarily used for the treatment of subarachnoid hemorrhage. As an impurity, it may arise during the synthesis or degradation of nimodipine and can affect the purity and efficacy of the final product. The compound typically exhibits characteristics common to organic molecules, including specific solubility profiles, stability under certain conditions, and potential reactivity with other chemical species. Its structural features may include functional groups that influence its chemical behavior, such as the presence of ester or amine groups. The identification and quantification of impurities like Nimodipine Impurity 4 are crucial in pharmaceutical development to ensure safety, efficacy, and compliance with regulatory standards. Analytical techniques such as high-performance liquid chromatography (HPLC) or mass spectrometry are often employed to detect and characterize such impurities in drug formulations.

CAS 116799-92-9

Nimodipine Impurity 4

Nimodipine Impurity 4

Ref: 4Z-N-159

Nimodipine Impurity 11

Ref: ST-EA-CP-N16017